Page last updated: 2024-08-21

cepharanthine and Colorectal Cancer

cepharanthine has been researched along with Colorectal Cancer in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Boonkrai, C; Limpanasittikul, W; Mutirangura, A; Payon, V; Rattanawong, A; Wonganan, P1
Kongsaden, C; Unson, S; Wonganan, P1

Other Studies

2 other study(ies) available for cepharanthine and Colorectal Cancer

ArticleYear
Cepharanthine exhibits a potent anticancer activity in p53-mutated colorectal cancer cells through upregulation of p21Waf1/Cip1.
    Oncology reports, 2018, Volume: 39, Issue:1

    Topics: Antineoplastic Agents, Phytogenic; Benzylisoquinolines; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colorectal Neoplasms; Cyclin-Dependent Kinase Inhibitor p21; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Gene Expression Regulation, Neoplastic; HT29 Cells; Humans; Mutation; Tumor Suppressor Protein p53; Up-Regulation

2018
Cepharanthine combined with 5-fluorouracil inhibits the growth of p53-mutant human colorectal cancer cells.
    Journal of Asian natural products research, 2020, Volume: 22, Issue:4

    Topics: Apoptosis; ATP Binding Cassette Transporter, Subfamily G, Member 2; Benzylisoquinolines; Cell Line, Tumor; Colorectal Neoplasms; Fluorouracil; Humans; Molecular Structure; Neoplasm Proteins; Tumor Suppressor Protein p53

2020